Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats

被引:13
作者
Alemdar, AY
Baker, KA
Sadi, D
McAlister, VC
Mendez, I
机构
[1] Dalhousie Univ, Neural Transplantat Lab, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada
[2] Dalhousie Univ, Div Gen Surg, Halifax, NS B3H 4H7, Canada
[3] Dalhousie Univ, Div Neurosurg, Dept Surg, Halifax, NS B3H 4H7, Canada
基金
加拿大健康研究院;
关键词
Parkinson's disease; neural transplantation; dopaminergic grafts; immunosuppression; tacrolimus; liposome; cell suspensions;
D O I
10.1006/exnr.2001.7801
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The most widely used immunosuppressant in neural transplantation is cyclosporine- A (CsA). However, CsA has significant toxic effects when administered systemically. Tacrolimus (FK506), is a more potent immunosuppressant than CsA and can be prepared in lipid micelles (LTAC). This liposomal preparation allows for the administration of tacrolimus to the site of transplantation, possibly reducing the systemic side effects of immunosuppression. In this study we investigated the ability of LTAC to promote graft survival in hemiparkinsonian rats implanted with fetal mouse xenografts when LTAC is administered systemically to the host, when added to the donor cell suspension, or in combination. Rats with unilateral 6-hydroxydopamine lesions were transplanted with 800,000 fetal mouse ventral mesencephalic (VM) cells and were randomly divided into four groups. Group I was not immunosuppressed; Group 2 received daily systemic injections of LTAC; Group 3 received LTAC within the cell suspensions of mouse VM cells; and Group 4 received LTAC in the cell suspensions along with daily systemic administration of LTAC. Transplanted rats were assessed for rotational behavior 3 and 6 weeks posttransplantation. Cell survival was assessed using tyrosine hydroxylase (TH) immunohistochemistry. A significant reduction in rotational scores was observed only in the group of animals receiving the combination of LTAC-treated donor cells and systemic LTAC administration. This functional improvement correlated with a significantly greater survival of TH-immunoreactive cells in this group of animals. The other groups had poor cell survival and no significant functional improvement. We conclude that a combination of systemic immunosuppression and treatment of the cell suspension with LTAC may be a superior strategy to optimize xenograft survival. This strategy may have important implications for clinical neural transplantation. (C) 2001 Elsevier Science.
引用
收藏
页码:416 / 424
页数:9
相关论文
共 52 条
  • [1] ESTIMATION OF NUCLEAR POPULATION FROM MICROTOME SECTIONS
    ABERCROMBIE, M
    [J]. ANATOMICAL RECORD, 1946, 94 (02): : 239 - 247
  • [2] Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells
    Apostolides, C
    Sanford, E
    Hong, M
    Mendez, I
    [J]. NEUROSCIENCE, 1998, 83 (02) : 363 - 372
  • [3] Motor and cognitive improvements in patients with Huntington's disease after neural transplantation
    Bachoud-Lévi, A
    Rémy, P
    Nguyen, JP
    Brugières, P
    Lefaucheur, JP
    Bourdet, C
    Baudic, S
    Gaura, V
    Maison, P
    Haddad, B
    Boissé, MF
    Grandmougin, T
    Jény, R
    Bartolomeo, P
    Dalla Barba, G
    Degos, JD
    Lisovoski, F
    Ergis, AM
    Pailhous, E
    Cesaro, P
    Hantraye, P
    Peschanski, M
    [J]. LANCET, 2000, 356 (9246) : 1975 - 1979
  • [4] Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease
    Baker, KA
    Hong, M
    Sadi, D
    Mendez, I
    [J]. EXPERIMENTAL NEUROLOGY, 2000, 162 (02) : 350 - 360
  • [5] Benninger Y, 2000, BRAIN PATHOL, V10, P330
  • [6] Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line
    Borlongan, CV
    Tajima, Y
    Trojanowski, J
    Lee, VMY
    Sanberg, PR
    [J]. NEUROREPORT, 1998, 9 (16) : 3703 - 3709
  • [7] Borlongan CV, 1996, NEUROL RES, V18, P297
  • [8] BRUNDIN P, 1988, EXP BRAIN RES, V70, P192
  • [9] BRUNDIN P, 1985, EXP BRAIN RES, V60, P204
  • [10] FK506 and cyclosporin a enhance the survival of cultured and grafted rat embryonic dopamine neurons
    Castilho, RF
    Hansson, O
    Brundin, P
    [J]. EXPERIMENTAL NEUROLOGY, 2000, 164 (01) : 94 - 101